We undertake consultancy research projects related to vaccine or anti-viral studies. For further details contact at shashankt@iisc.ac.in
VACCINE STUDIES
ANTIVIRAL STUDIES
SERVICES PROVIDED
RT-PCR related assays
SARS-CoV-2 Viral load, pro- and anti-inflammatory cytokine levels.
ELISA-based assays
SARS-CoV-2 RBD-specific antibodies and cytokine levels.
Histology Studies
Lungs, spleen, liver, nasal turbinates, etc.
Neutralization assays
Live virus and Pseudovirus-based assays
Small-animal studies
Mice and hamsters to monitor body weight, clinical signs, and organ gross morphology.
Cytotoxicity and antiviral assays
In multiple cell lines and organoid models
NEWS
- Japan’s Sharp Naturizer sanitizer solution proves effectiveness against COVID-19 (biospectrumasia.com)
- Sharp Workspace Procat Photocatalyst found effective against SARS- CoV-2 (aninews.in)
- Biomoneta’s ZeBox effective against airborne SARS-CoV-2 (biospectrumindia.com)
- DCGI approves indigenous mRNA Covid jab for emergency use in adults: Report | Business Standard News (business-standard.com)
Dr. Shashank Tripathi
Faculty Incharge
VIRAL Biosafety Level-3 Laboratory
Centre for Infectious Disease Research (CIDR)
MCB Department
Indian Institute of Science
CV Raman Avenue
Bangalore-560012
India
080-2292884/3063
Dr. Rohan Narayan
Incharge
VIRAL Biosafety Level-3 Laboratory
Centre for Infectious Disease Research (CIDR)
Indian Institute of Science
CV Raman Avenue
Bangalore-560012
India
080-2292884/3063















